Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2011

Open Access 01-12-2011 | Debate

Exploratory trials, confirmatory observations: A new reasoning model in the era of patient-centered medicine

Author: José A Sacristán

Published in: BMC Medical Research Methodology | Issue 1/2011

Login to get access

Abstract

Background

The prevailing view in therapeutic clinical research today is that observational studies are useful for generating new hypotheses and that controlled experiments (i.e., randomized clinical trials, RCTs) are the most appropriate method for assessing and confirming the efficacy of interventions.

Discussion

The current trend towards patient-centered medicine calls for alternative ways of reasoning, and in particular for a shift towards hypothetico-deductive logic, in which theory is adjusted in light of individual facts. A new model of this kind should change our approach to drug research and development, and regulation. The assessment of new therapeutic agents would be viewed as a continuous process, and regulatory approval would no longer be regarded as the final step in the testing of a hypothesis, but rather, as the hypothesis-generating step.
The main role of RCTs in this patient-centered research paradigm would be to generate hypotheses, while observations would serve primarily to test their validity for different types of patients. Under hypothetico-deductive logic, RCTs are considered "exploratory" and observations, "confirmatory".

Summary

In this era of tailored therapeutics, the answers to therapeutic questions cannot come exclusively from methods that rely on data aggregation, the analysis of similarities, controlled experiments, and a search for the best outcome for the average patient; they must also come from methods based on data disaggregation, analysis of subgroups and individuals, an integration of research and clinical practice, systematic observations, and a search for the best outcome for the individual patient. We must look not only to evidence-based medicine, but also to medicine-based evidence, in seeking the knowledge that we need.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sackett DL, Richardson WS, Rosenberg W, Haynes RB: Evidence-based medicine: how to practice and teach EBM. 1997, New York: Churchill Livingstone Sackett DL, Richardson WS, Rosenberg W, Haynes RB: Evidence-based medicine: how to practice and teach EBM. 1997, New York: Churchill Livingstone
2.
go back to reference Mant M: Can randomized trials inform clinical decisions about individual patients?. Lancet. 1999, 353: 743-6. 10.1016/S0140-6736(98)09102-8.CrossRefPubMed Mant M: Can randomized trials inform clinical decisions about individual patients?. Lancet. 1999, 353: 743-6. 10.1016/S0140-6736(98)09102-8.CrossRefPubMed
3.
go back to reference Feinstein AR: Twentieth century paradigms that threaten both scientific and human medicine in the twenty-first century. J Clin Epidemiol. 1996, 49: 615-7. 10.1016/0895-4356(96)00040-6.CrossRefPubMed Feinstein AR: Twentieth century paradigms that threaten both scientific and human medicine in the twenty-first century. J Clin Epidemiol. 1996, 49: 615-7. 10.1016/0895-4356(96)00040-6.CrossRefPubMed
4.
go back to reference Keirns CC, Goold SD: Patient-centered care and preference-sensitive decision making. JAMA. 2009, 302: 1805-6. 10.1001/jama.2009.1550.CrossRefPubMed Keirns CC, Goold SD: Patient-centered care and preference-sensitive decision making. JAMA. 2009, 302: 1805-6. 10.1001/jama.2009.1550.CrossRefPubMed
5.
go back to reference Sox HC, Greenfield S: Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009, 151: 203-5.CrossRefPubMed Sox HC, Greenfield S: Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009, 151: 203-5.CrossRefPubMed
6.
go back to reference Conway PH, Clancy C: Charting a path from comparative effectiveness funding to improved patient-centered health care. JAMA. 2010, 303: 985-6. 10.1001/jama.2010.259.CrossRefPubMed Conway PH, Clancy C: Charting a path from comparative effectiveness funding to improved patient-centered health care. JAMA. 2010, 303: 985-6. 10.1001/jama.2010.259.CrossRefPubMed
7.
go back to reference Ioannidis JP, Lau J: Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient. J Clin Epidemiol. 1998, 51: 709-11. 10.1016/S0895-4356(98)00042-0.CrossRefPubMed Ioannidis JP, Lau J: Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient. J Clin Epidemiol. 1998, 51: 709-11. 10.1016/S0895-4356(98)00042-0.CrossRefPubMed
9.
go back to reference Feinstein AR, Horwitz IR: Problems in the "evidence" of "evidence-based medicine". Am J Med. 1997, 103: 529-35. 10.1016/S0002-9343(97)00244-1.CrossRefPubMed Feinstein AR, Horwitz IR: Problems in the "evidence" of "evidence-based medicine". Am J Med. 1997, 103: 529-35. 10.1016/S0002-9343(97)00244-1.CrossRefPubMed
10.
go back to reference Schwartz D, Lellouch J: Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis. 1967, 20: 637-48. 10.1016/0021-9681(67)90041-0.CrossRefPubMed Schwartz D, Lellouch J: Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis. 1967, 20: 637-48. 10.1016/0021-9681(67)90041-0.CrossRefPubMed
11.
go back to reference Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003, 290: 1624-32. 10.1001/jama.290.12.1624.CrossRefPubMed Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003, 290: 1624-32. 10.1001/jama.290.12.1624.CrossRefPubMed
12.
go back to reference Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz S: Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009, 151: 206-9.CrossRefPubMed Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz S: Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009, 151: 206-9.CrossRefPubMed
14.
go back to reference Yusuf S, Collins R, Peto R: Why do we need some large simple randomized trials. Stat Med. 1984, 3: 409-20. 10.1002/sim.4780030421.CrossRefPubMed Yusuf S, Collins R, Peto R: Why do we need some large simple randomized trials. Stat Med. 1984, 3: 409-20. 10.1002/sim.4780030421.CrossRefPubMed
15.
go back to reference Mullins CD, Whicher D, Reese ES, Tunis S: Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials. Pharmacoeconomics. 2010, 28: 969-76. 10.2165/11536160-000000000-00000.CrossRefPubMed Mullins CD, Whicher D, Reese ES, Tunis S: Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials. Pharmacoeconomics. 2010, 28: 969-76. 10.2165/11536160-000000000-00000.CrossRefPubMed
16.
go back to reference Hilbrich L, Sleight P: Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J. 2006, 27: 2158-64. 10.1093/eurheartj/ehl152.CrossRefPubMed Hilbrich L, Sleight P: Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J. 2006, 27: 2158-64. 10.1093/eurheartj/ehl152.CrossRefPubMed
17.
go back to reference Greenfield S, Kravitz R, Duan N, Kaplan SH: Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment. Am J Med. 2007, 120: S3-S9.CrossRefPubMed Greenfield S, Kravitz R, Duan N, Kaplan SH: Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment. Am J Med. 2007, 120: S3-S9.CrossRefPubMed
18.
go back to reference Simon G: Choosing a first line antidepressant: equal on average does not mean equal for everyone. JAMA. 2001, 286: 3003-4. 10.1001/jama.286.23.3003.CrossRefPubMed Simon G: Choosing a first line antidepressant: equal on average does not mean equal for everyone. JAMA. 2001, 286: 3003-4. 10.1001/jama.286.23.3003.CrossRefPubMed
19.
go back to reference Upshur RE: If not evidence, then what? Or does medicine really need a base?. J Eval Clin Pract. 2002, 8: 113-9. 10.1046/j.1365-2753.2002.00356.x.CrossRefPubMed Upshur RE: If not evidence, then what? Or does medicine really need a base?. J Eval Clin Pract. 2002, 8: 113-9. 10.1046/j.1365-2753.2002.00356.x.CrossRefPubMed
20.
go back to reference Poynard T, Munteanu M, Ratziu V, Benhamou Y, Di Martino V, Taieb J, Opolon P: Truth survival in clinical research: an evidence-based requiem?. Ann Intern Med. 2002, 136: 888-95.CrossRefPubMed Poynard T, Munteanu M, Ratziu V, Benhamou Y, Di Martino V, Taieb J, Opolon P: Truth survival in clinical research: an evidence-based requiem?. Ann Intern Med. 2002, 136: 888-95.CrossRefPubMed
21.
go back to reference Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM: Statistical in medicine: Reporting of subgroup analyses in clinical trials. N Engl J Med. 2007, 357: 2189-94. 10.1056/NEJMsr077003.CrossRefPubMed Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM: Statistical in medicine: Reporting of subgroup analyses in clinical trials. N Engl J Med. 2007, 357: 2189-94. 10.1056/NEJMsr077003.CrossRefPubMed
22.
go back to reference Rothwell PM: Subgroup analysis in randomized controlled trials: importance, indications, and interpretation. Lancet. 2005, 365: 76-86. Rothwell PM: Subgroup analysis in randomized controlled trials: importance, indications, and interpretation. Lancet. 2005, 365: 76-86.
23.
go back to reference Simon R, Maitournam A: Evaluating the efficiency of targeted designs for randomized clinical trials. J Clin Oncol. 2004, 10: 6759-63. Simon R, Maitournam A: Evaluating the efficiency of targeted designs for randomized clinical trials. J Clin Oncol. 2004, 10: 6759-63.
25.
go back to reference Jenicek M: Clinical case reporting in evidence-based medicine. Oxford Butterworth-Heinemann. 1999, 117- Jenicek M: Clinical case reporting in evidence-based medicine. Oxford Butterworth-Heinemann. 1999, 117-
26.
28.
go back to reference Greenland S: Induction versus Popper. Substance versus semantics. Int J Epidemiol. 1998, 27: 543-8. 10.1093/ije/27.4.543.CrossRefPubMed Greenland S: Induction versus Popper. Substance versus semantics. Int J Epidemiol. 1998, 27: 543-8. 10.1093/ije/27.4.543.CrossRefPubMed
29.
go back to reference Merriam-Webster Online Dictionary copyright © 2011 by Merriam-Webster, Incorporated Merriam-Webster Online Dictionary copyright © 2011 by Merriam-Webster, Incorporated
30.
go back to reference Carwright N: Are RCTs the gold standard?. Biosocieties. 2007, 2: 11-20. 10.1017/S1745855207005029.CrossRef Carwright N: Are RCTs the gold standard?. Biosocieties. 2007, 2: 11-20. 10.1017/S1745855207005029.CrossRef
31.
go back to reference Bluhm RB: Evidence-based medicine and philosophy of science. J Eval Clin Pract. 2010, 16: 363-4. 10.1111/j.1365-2753.2010.01401.x.CrossRefPubMed Bluhm RB: Evidence-based medicine and philosophy of science. J Eval Clin Pract. 2010, 16: 363-4. 10.1111/j.1365-2753.2010.01401.x.CrossRefPubMed
32.
go back to reference Rawlins M: Harveian Oration. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008, 372: 2152-61. 10.1016/S0140-6736(08)61930-3.CrossRefPubMed Rawlins M: Harveian Oration. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008, 372: 2152-61. 10.1016/S0140-6736(08)61930-3.CrossRefPubMed
33.
go back to reference Sacristan JA: Evidence from randomized controlled trials, meta-analyses, and subgroup analyses. JAMA. 2010, 303: 1253-4.CrossRefPubMed Sacristan JA: Evidence from randomized controlled trials, meta-analyses, and subgroup analyses. JAMA. 2010, 303: 1253-4.CrossRefPubMed
34.
go back to reference Skrabanek P: In defense of destructive criticism. Perspect Biol Med. 1986, 30: 9-26.CrossRef Skrabanek P: In defense of destructive criticism. Perspect Biol Med. 1986, 30: 9-26.CrossRef
35.
go back to reference Davey Smith G: Reflections on the limitations to epidemiology. J Clin Epidemiol. 2001, 54: 325-31. 10.1016/S0895-4356(00)00334-6.CrossRef Davey Smith G: Reflections on the limitations to epidemiology. J Clin Epidemiol. 2001, 54: 325-31. 10.1016/S0895-4356(00)00334-6.CrossRef
36.
go back to reference Fricker J: Time to reform in the drug-development process. Lancet Oncol. 2008, 9: 1125-6. 10.1016/S1470-2045(08)70297-3.CrossRefPubMed Fricker J: Time to reform in the drug-development process. Lancet Oncol. 2008, 9: 1125-6. 10.1016/S1470-2045(08)70297-3.CrossRefPubMed
37.
go back to reference Jenicek M: Clinical case reports: sources of boredom or valuable pieces of evidence?. Nat J India. 2001, 14: 193-4. Jenicek M: Clinical case reports: sources of boredom or valuable pieces of evidence?. Nat J India. 2001, 14: 193-4.
38.
go back to reference Feinstein AR: Clinical judgment revisited: the distraction of quantitative models. Ann Intern Med. 1994, 120: 799-805.CrossRefPubMed Feinstein AR: Clinical judgment revisited: the distraction of quantitative models. Ann Intern Med. 1994, 120: 799-805.CrossRefPubMed
39.
go back to reference Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM, Krauss RM, McCarty CA, Davis RL, Skaar T, Lamba J, Savova G: The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther. 2011, 89: 379-86. 10.1038/clpt.2010.260.CrossRefPubMedPubMedCentral Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM, Krauss RM, McCarty CA, Davis RL, Skaar T, Lamba J, Savova G: The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther. 2011, 89: 379-86. 10.1038/clpt.2010.260.CrossRefPubMedPubMedCentral
40.
go back to reference Fraenkel L, Fried TR: Individualized medical decision making. Necessary, achievable, but not yet attainable. Arch Intern Med. 2010, 170: 566-9. 10.1001/archinternmed.2010.8.CrossRefPubMedPubMedCentral Fraenkel L, Fried TR: Individualized medical decision making. Necessary, achievable, but not yet attainable. Arch Intern Med. 2010, 170: 566-9. 10.1001/archinternmed.2010.8.CrossRefPubMedPubMedCentral
41.
go back to reference Charlton BC: Individual case studies in primary health care. Fam Pract. 1999, 16: 1-2. 10.1093/fampra/16.1.1.CrossRefPubMed Charlton BC: Individual case studies in primary health care. Fam Pract. 1999, 16: 1-2. 10.1093/fampra/16.1.1.CrossRefPubMed
42.
go back to reference Charlton BG: Individual case studies in clinical research. J Eval Clin Practice. 1998, 4: 147-55. 10.1111/j.1365-2753.1998.tb00081.x.CrossRef Charlton BG: Individual case studies in clinical research. J Eval Clin Practice. 1998, 4: 147-55. 10.1111/j.1365-2753.1998.tb00081.x.CrossRef
43.
go back to reference Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS: Users' guides to the medical literature. XXV. Evidence-based medicine: principles for applying the users' guides to patient care. JAMA. 2000, 284: 1290-6. 10.1001/jama.284.10.1290.CrossRefPubMed Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS: Users' guides to the medical literature. XXV. Evidence-based medicine: principles for applying the users' guides to patient care. JAMA. 2000, 284: 1290-6. 10.1001/jama.284.10.1290.CrossRefPubMed
44.
go back to reference Nikles J, Clavarino AM, Del Mar CB: Using n-of-1 trials as a clinical tool to improve prescribing. Br J Gen Practice. 2005, 55: 175-80. Nikles J, Clavarino AM, Del Mar CB: Using n-of-1 trials as a clinical tool to improve prescribing. Br J Gen Practice. 2005, 55: 175-80.
45.
go back to reference Rodríguez-Artalejo F, Ortún V: General treatments versus personalized treatments. Gest Clin Sanit. 2003, 5: 87-8. Rodríguez-Artalejo F, Ortún V: General treatments versus personalized treatments. Gest Clin Sanit. 2003, 5: 87-8.
46.
go back to reference Steiner JF: Talking about treatment: the language of populations and the language of individuals. Ann Intern Med. 1999, 130: 618-22.CrossRefPubMed Steiner JF: Talking about treatment: the language of populations and the language of individuals. Ann Intern Med. 1999, 130: 618-22.CrossRefPubMed
47.
go back to reference Sacristán JA: Medicine-based evidence. Med Clin. 1999, 112 (Suppl 1): 9-11. Sacristán JA: Medicine-based evidence. Med Clin. 1999, 112 (Suppl 1): 9-11.
Metadata
Title
Exploratory trials, confirmatory observations: A new reasoning model in the era of patient-centered medicine
Author
José A Sacristán
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2011
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-11-57

Other articles of this Issue 1/2011

BMC Medical Research Methodology 1/2011 Go to the issue